SB24-203
Prescription Drug Board Consider Rare Disease Advisory Council
Concerning requiring the Colorado prescription drug affordability review board to consider input from the Colorado rare disease advisory council under certain circumstances.
04/29/2024 | House Committee on Health & Human Services Refer Unamended to House Committee of the Whole
2024 Regular Session
Bill
Insurance